* We recommend a score >= 0.08 for meaningful Gene-Disease associations
| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name | DisGeNet_sourceDB | |
| 5058 | PAK1 | C1458155 | Mammary Neoplasms | 0.217221655141522 | BEFREE;CTD_human;LHGDN |
| 5058 | PAK1 | C0007134 | Renal Cell Carcinoma | 0.200549453568426 | BEFREE;CTD_human |
| 5058 | PAK1 | C0033687 | Proteinuria | 0.2 | CTD_human |
| 5058 | PAK1 | C0242488 | Acute Lung Injury | 0.08 | RGD |
| 5058 | PAK1 | C2936380 | Neointima | 0.08 | RGD |
| 5058 | PAK1 | C0006142 | Malignant neoplasm of breast | 0.0095499249128286 | BEFREE;GAD |
| 5058 | PAK1 | C0678222 | Breast Carcinoma | 0.0068681696053275 | BEFREE |
| 5058 | PAK1 | C0596263 | Carcinogenesis | 0.0035714481947703 | BEFREE |
| 5058 | PAK1 | C0027627 | Neoplasm Metastasis | 0.0030219946263441 | BEFREE |
| 5058 | PAK1 | C0002395 | Alzheimer's Disease | 0.00300763924902685 | BEFREE;LHGDN |
| 5058 | PAK1 | C0022665 | Kidney Neoplasm | 0.00300763924902685 | BEFREE;LHGDN |
| 5058 | PAK1 | C0025202 | melanoma | 0.00300763924902685 | BEFREE;LHGDN |
| 5058 | PAK1 | C0919267 | ovarian neoplasm | 0.00300763924902685 | BEFREE;LHGDN |
| 5058 | PAK1 | C0019693 | HIV Infections | 0.0029564820917142 | BEFREE;GAD |
| 5058 | PAK1 | C0009404 | Colorectal Neoplasms | 0.00273291246481375 | LHGDN |
| 5058 | PAK1 | C0040136 | Thyroid Neoplasm | 0.00273291246481375 | LHGDN |
| 5058 | PAK1 | C3714514 | Infection | 0.00273291246481375 | LHGDN |
| 5058 | PAK1 | C0040336 | Tobacco Use Disorder | 0.002407028523288 | GAD |
| 5058 | PAK1 | C0546837 | Malignant neoplasm of esophagus | 0.002407028523288 | GAD |
| 5058 | PAK1 | C0009402 | Colorectal Carcinoma | 0.0021978142737048 | BEFREE |
| 5058 | PAK1 | C1527249 | Colorectal Cancer | 0.0021978142737048 | BEFREE |
| 5058 | PAK1 | C0007102 | Malignant tumor of colon | 0.0013736339210655 | BEFREE |
| 5058 | PAK1 | C0024623 | Malignant neoplasm of stomach | 0.0013736339210655 | BEFREE |
| 5058 | PAK1 | C0178874 | Tumor Progression | 0.0013736339210655 | BEFREE |
| 5058 | PAK1 | C0376358 | Malignant neoplasm of prostate | 0.0013736339210655 | BEFREE |
| 5058 | PAK1 | C0699790 | Colon Carcinoma | 0.0013736339210655 | BEFREE |
| 5058 | PAK1 | C0699791 | Stomach Carcinoma | 0.0013736339210655 | BEFREE |
| 5058 | PAK1 | C2239176 | Liver carcinoma | 0.0013736339210655 | BEFREE |
| 5058 | PAK1 | C0029925 | Ovarian Carcinoma | 0.0010989071368524 | BEFREE |
| 5058 | PAK1 | C0600139 | Prostate carcinoma | 0.0010989071368524 | BEFREE |
| 5058 | PAK1 | C0162678 | Neurofibromatoses | 0.0008241803526393 | BEFREE |
| 5058 | PAK1 | C0235974 | Pancreatic carcinoma | 0.0008241803526393 | BEFREE |
| 5058 | PAK1 | C0242379 | Malignant neoplasm of lung | 0.0008241803526393 | BEFREE |
| 5058 | PAK1 | C0346647 | Malignant neoplasm of pancreas | 0.0008241803526393 | BEFREE |
| 5058 | PAK1 | C0677886 | Epithelial ovarian cancer | 0.0008241803526393 | BEFREE |
| 5058 | PAK1 | C0684249 | Carcinoma of lung | 0.0008241803526393 | BEFREE |
| 5058 | PAK1 | C1306460 | Primary malignant neoplasm of lung | 0.0008241803526393 | BEFREE |
| 5058 | PAK1 | C0005684 | Malignant neoplasm of urinary bladder | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0005695 | Bladder Neoplasm | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0009319 | Colitis | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0014175 | Endometriosis | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0017636 | Glioblastoma | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0021390 | Inflammatory Bowel Diseases | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0023903 | Liver neoplasms | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0027831 | Neurofibromatosis 1 | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0027832 | Neurofibromatosis 2 | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0032584 | polyps | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0033578 | Prostatic Neoplasms | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0424295 | Hyperactive behavior | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0476089 | Endometrial Carcinoma | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0686619 | Secondary malignant neoplasm of lymph node | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0699885 | Carcinoma of bladder | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C1140680 | Malignant neoplasm of ovary | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C1332166 | Adenocarcinoma of the Gastroesophageal Junction | 0.0005494535684262 | BEFREE |
| 5058 | PAK1 | C0001418 | Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0001430 | Adenoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0002893 | Refractory anemias | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0003850 | Arteriosclerosis | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0003873 | Rheumatoid Arthritis | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0004153 | Atherosclerosis | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0007103 | Malignant neoplasm of endometrium | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0007114 | Malignant neoplasm of skin | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0007115 | Malignant neoplasm of thyroid | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0007124 | Noninfiltrating Intraductal Carcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0007137 | Squamous cell carcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0008497 | Choriocarcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0009324 | Ulcerative Colitis | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0010709 | Cyst | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0018790 | Cardiac Arrest | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0019163 | Hepatitis B | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0020217 | Hydatidiform Mole | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0023418 | leukemia | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0023467 | Leukemia, Myelocytic, Acute | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0024299 | Lymphoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0025286 | Meningioma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0027809 | Neurilemmoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0032927 | Precancerous Conditions | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0035412 | Rhabdomyosarcoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0042109 | Urticaria | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0151514 | Atrophic condition of skin | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0151546 | Oral Cavity Carcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0206666 | Trophoblastic Tumor, Placental Site | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0206687 | Carcinoma, Endometrioid | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0206754 | Neuroendocrine Tumors | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0220641 | Lip and Oral Cavity Carcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0221232 | Welts | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0268621 | Hepatic methionine adenosyltransferase deficiency | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0271650 | Impaired glucose tolerance | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0278689 | Ovarian epithelial cancer recurrent | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0280280 | stage, prostate cancer | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0332996 | Persistent embryonic structure | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0333186 | Restenosis | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0334108 | Multiple polyps | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0341858 | Endometriosis of uterus | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0346957 | Disseminated Malignant Neoplasm | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0346976 | Secondary malignant neoplasm of pancreas | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0393576 | Chorea Acanthocytosis Syndrome | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0524851 | Neurodegenerative Disorders | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0549473 | Thyroid carcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0553665 | Skin endocrine disorder | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0598766 | Leukemogenesis | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0740457 | Malignant neoplasm of kidney | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0751690 | Malignant Peripheral Nerve Sheath Tumor | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C0949059 | Polyp of large intestine | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1112474 | Esophageal Small Cell Neuroendocrine Carcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1135868 | Gestational Trophoblastic Neoplasms | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1261473 | Sarcoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1319315 | Adenocarcinoma of large intestine | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1335302 | Pancreatic Ductal Adenocarcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1378703 | Renal carcinoma | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1402315 | Vascular lesions | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1519670 | Tumor Angiogenesis | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1535939 | Pneumocystis jiroveci pneumonia | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1853926 | NONAKA MYOPATHY | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C1883486 | Uterine Corpus Cancer | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C2347126 | Microscopic Polyarteritis | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C2931618 | Gestational trophoblastic disease | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C3272805 | Colorectal Adenomatous Polyp | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C3463824 | MYELODYSPLASTIC SYNDROME | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C3463897 | HYDATIDIFORM MOLE, RECURRENT, 1 | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C3539909 | Allergic disposition | 0.0002747267842131 | BEFREE |
| 5058 | PAK1 | C3714756 | Intellectual Disability | 0.0002747267842131 | BEFREE |